148 related articles for article (PubMed ID: 31252588)
21. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
22. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
[TBL] [Abstract][Full Text] [Related]
23. CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective Analysis.
Hecht S; Boxhammer E; Kaufmann R; Scharinger B; Reiter C; Kammler J; Kellermair J; Hammerer M; Blessberger H; Steinwender C; Hoppe UC; Hergan K; Lichtenauer M
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143238
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
25. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19.
Sabbatinelli J; Di Rosa M; Giuliani A; Domenichelli M; Bonfigli AR; Sarzani R; Cherubini A; Antonicelli R; Burattini M; Corsonello A; Galeazzi R; Babini L; Moretti M; Procopio AD; Lattanzio F; Olivieri F
Mech Ageing Dev; 2023 Dec; 216():111876. PubMed ID: 37802485
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
[TBL] [Abstract][Full Text] [Related]
28. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
[TBL] [Abstract][Full Text] [Related]
29. ST2 elevation in heart failure, predictive of a high early mortality.
Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers and diagnostics in heart failure.
Gaggin HK; Januzzi JL
Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
[TBL] [Abstract][Full Text] [Related]
31. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
32. Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level.
Fujita SI; Tanaka S; Maeda D; Morita H; Fujisaka T; Takeda Y; Ito T; Ishizaka N
PLoS One; 2017; 12(1):e0170546. PubMed ID: 28135310
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
34. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
35. Correlations of GDF-15 with sST2, MMPs, and worsening functional capacity in idiopathic dilated cardiomyopathy: Can we gain new insights into the pathophysiology?
Nair N; Gongora E
J Circ Biomark; 2018; 7():1849454417751735. PubMed ID: 29375722
[TBL] [Abstract][Full Text] [Related]
36. Altered function of the left ventricle and clinical significance of heart-type fatty acid-binding protein in cardiac dysfunction among patients with sepsis.
Weng G; Tian P; Yan X; Cheng Q
Exp Ther Med; 2020 Nov; 20(5):58. PubMed ID: 32952648
[TBL] [Abstract][Full Text] [Related]
37. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
38. Multi-Marker Approach in Patients with Acute Chest Pain in the Emergency Department.
Piccioni A; Baroni S; Manca F; Sarlo F; Savioli G; Candelli M; Bronzino A; Covino M; Gasbarrini A; Franceschi F
J Pers Med; 2024 May; 14(6):. PubMed ID: 38929785
[TBL] [Abstract][Full Text] [Related]
39. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies.
Topf A; Mirna M; Bacher N; Paar V; Motloch LJ; Ohnewein B; Larbig R; Grueninger J; Hoppe UC; Lichtenauer M; Pistulli R
Front Cardiovasc Med; 2021; 8():700169. PubMed ID: 34805296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
